Creative Planning Uni Qure N.V. Transaction History

Creative Planning

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$29.97 - $37.17 $197,202 - $244,578	-6,580 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$29.24 - $42.03 $150,410 - $216,202	-5,144 Reduced 43.88%	6,580 $222,000
Q4 2020 Jan 29, 2021	BUY	$35.35 - $50.67 $414,443 - $594,055	11,724 New	11,724 $424,000
Q4 2019 Jan 30, 2020	SELL	$37.13 - $74.62 $1.15 Million - $2.31 Million	-31,000 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$39.36 - $76.8 $1.22 Million - $2.38 Million	31,000 New	31,000 $1.22 Million
Q2 2018 Jul 20, 2018	SELL	$21.96 - $39.94 $439,200 - $798,800	-20,000 Closed	0 $0
Q1 2018 Apr 18, 2018	BUY	$17.1 - $26.61 $342,000 - $532,200	20,000 New	20,000 $470,000
Q4 2017 Jan 17, 2018	SELL	$9.47 - $19.59 $280,264 - $579,766	-29,595 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$7.7 - $9.6 $227,881 - $284,112	29,595	29,595 $284,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.